Boots Unveils SureLeaf Medical Cannabis Service
UK pharmacy chain Boots has announced the launch of SureLeaf, a specialist medical cannabis service. The service gives eligible patients living with chronic pain, generalized anxiety disorder or insomnia access to consultant-led assessment, treatment and ongoing clinical care.
The new service expands the range of specialist healthcare available through Boots Online Doctor. It gives eligible patients another treatment option to consider and greater access to clinical expertise.
Patients aged 25 or over with an eligible condition can begin their assessment online. Suitability is reviewed by the clinical team before progressing to a video consultation with a consultant in the relevant medical specialty who is on the General Medical Council Specialist Register.
Patients must have previously tried conventional treatments without achieving adequate symptom relief. Any proposed prescription will be independently reviewed by a multidisciplinary clinical team that includes a second, independent consultant, before treatment begins.
“At Boots, we’re committed to making healthcare more accessible and helping people find the right support for their individual needs. Millions of people live with ongoing pain and for some, conventional treatments do not provide adequate symptom relief,” said Jamie Kerruish, chief healthcare officer at Boots, in a statement.
Clinical Safeguards And Ongoing Monitoring
SureLeaf brings together specialist consultants, multidisciplinary clinical oversight and ongoing patient monitoring throughout treatment. Once treatment begins, patients receive ongoing clinical support and monitoring, including an initial review after 28 days followed by reviews at least every three months.
Validated questionnaires will be used throughout treatment to assess relevant areas including quality of life, pain, anxiety, sleep and mood. These help clinicians monitor the effectiveness of treatment.
“Medical cannabis is not appropriate for everyone and prescribing decisions need to be made carefully on an individual patient basis. SureLeaf has therefore been designed with strong clinical safeguards and specialist oversight at every stage, so treatment is only considered for patients where it is clinically appropriate,” said Dr. David Gwynne, medical director for Boots Online Doctor, in a statement.
Kerruish said the impact of inadequate symptom relief can affect everyday life, from working and sleeping well to spending time with family. He said the service is ultimately about helping people explore appropriate options to better manage their symptoms and improve their quality of life.
Research Partnership With University Of Nottingham
Alongside the launch, Boots and the University of Nottingham are exploring a collaborative research programme. The programme would build on existing real-world evidence and understanding of medical cannabis in chronic pain management.
The work would build on the existing partnership between the two organisations. That partnership is based on a shared commitment to improve patient care through evidence led innovation.
The launch represents a significant step forward for the legal cannabis market in the country. Boots announced the service today.

